Biopharma company Mendus is drawing SEK 16.5m from the second tranche of its loan facility with Fenja Capital II, which totals SEK 50m. The company previously drew SEK 30m in January 2026. Following ...
The Etcamah results came a week after the U.S. granted approval for the drug for advanced breast cancer upon the detection of a specific mutation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results